文献速递眼底病与葡萄膜炎

非感染性葡萄膜炎中的时间权衡效用值

Time Trade-off Utility Values in Noninfectious Uveitis.
PubMed 文献 · Am J Ophthalmol · 2019-06-13

在美国旧金山一家三级葡萄膜炎中心连续纳入104例非感染性葡萄膜炎成人患者,采用访谈引导的时间权衡(TTO)效用调查。中位TTO评分为0.975,较差眼视力、口服糖皮质激素超过6个月和当前使用抗抑郁药与较低TTO评分相关。口服糖皮质激素超过6个月者换取20%及以上剩余生命年(TTO≤0.8)的可能性是不使用者的10.5倍。

要点

  • 非感染性葡萄膜炎患者中位TTO评分为0.975(IQR 0.8-1.0),对应中位愿以1.28年剩余生命换取健康双眼。
  • 较差眼视力、口服糖皮质激素超过6个月、当前使用抗抑郁药与较低TTO评分相关(P=.008、P=.006、P=.008)。
  • 口服糖皮质激素超过6个月者换取20%及以上剩余生命年(TTO≤0.8)的可能性是不使用者10.5倍(95%CI 2.3-48.1;P=.002)。

核心结论

  • 非感染性葡萄膜炎患者经TTO评估的生活质量有可测量但幅度不大的下降,下降与较差眼视力和长期口服糖皮质激素使用显著相关。

研究设计与样本

  • 时间权衡效用分析,设置于美国加利福尼亚州旧金山一家三级葡萄膜炎中心。
  • 2016年11月至2017年2月连续纳入104例非感染性葡萄膜炎成人患者,采用访谈引导问卷调查收集TTO效用值。

主要发现

  • 中位TTO评分为0.975(IQR 0.8-1.0),对应中位愿以1.28年剩余生命换取健康双眼(IQR 0-6.29)。
  • 控制年龄和性别后,较差眼视力、口服糖皮质激素超过6个月、当前使用抗抑郁药与较低TTO评分相关(P=.008、P=.006、P=.008)。
  • 口服糖皮质激素超过6个月者(不论剂量)换取20%及以上剩余生命年(TTO≤0.8)的可能性是不使用口服糖皮质激素者的10.5倍(95%CI 2.3-48.1;P=.002)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate time trade-off (TTO) utility values in patients with noninfectious uveitis and determine whether patient demographics and clinical characteristics are associated with utility scores. DESIGN: Time trade-off utility analysis. METHODS: Setting: A tertiary care uveitis center in San Francisco, California, USA. PATIENT POPULATION: One hundred and four consecutive adults with noninfectious uveitis, enrolled between November 2016 and February 2017. MAIN OUTCOME MEASURES: TTO utility values, as collected by an interviewer-guided survey. Information regarding general health, ocular symptoms, and religion was also collected and medical record review was conducted to record anatomic location of uveitis, disease activity, visual acuity, and treatments. Multivariable regression analysis with backward selection was used to identify variables associated with TTO values. RESULTS: Median TTO score was 0.975 (interquartile range [IQR]: 0.8-1.0), corresponding to trading a median 1.28 years of remaining life for healthy eyes (IQR: 0-6.29). Regression analysis revealed that worse eye visual acuity, >6 months of oral corticosteroid use, and current antidepressant use were associated with lower TTO scores (P = .008, P = .006, P = .008, respectively), controlling for age and sex. In particular, patients who had been taking oral corticosteroids for more than 6 months, regardless of dose, were 10.5 times more likely to trade 20% or more years of remaining life (TTO ≤0.8) than patients not taking oral corticosteroids (95% confidence interval: 2.3, 48.1; P = .002). CONCLUSIONS: Patients with noninfectious uveitis had measurable, though modest, reductions in quality of life, as assessed by TTO, and these decreases were significantly associated with visual acuity in the worse eye and long-term oral corticosteroid use.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Niemeyer KM, Gonzales JA, Doan T, et al. Time Trade-off Utility Values in Noninfectious Uveitis. Am J Ophthalmol. 2019. PMID: 31201795. doi:10.1016/j.ajo.2019.06.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。